The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.

Our team of authors, Sally Shorthose, Peter Willis, Chris de Mauny and Pieter Erasmus have written the UK chapter of this publication.

Read the full chapter here.